The Role of Phytochemicals in Managing Neuropathic Pain: How Much Progress Have We Made?
Open Access
Abstract
Neuropathic pain is a complex and debilitating condition resulting from nerve damage, characterized by sensations such as burning, tingling, and shooting pain. It is often associated with conditions such as multiple sclerosis (MS), Guillain-Barré syndrome (GBS), and diabetic polyneuropathy. Conventional pain therapies frequently provide limited relief and are accompanied by significant side effects, emphasizing the need to explore alternative treatment options. Phytochemicals, which are bioactive compounds derived from plants, have gained attention for their potential in neuropathic pain management due to their diverse pharmacological properties, including anti-inflammatory, antioxidant, and neuroprotective effects. This review evaluates the mechanisms by which specific phytochemicals, such as curcumin, resveratrol, and capsaicin, influence neuropathic pain pathways, particularly their role in modulating inflammatory processes, reducing oxidative stress, and interacting with ion channels and signaling pathways. While curcumin and resveratrol are primarily considered dietary supplements, their roles in managing neuropathic pain require further clinical investigation to establish their efficacy and safety. In contrast, capsaicin is an active ingredient derived from chili peppers that has been developed into approved topical treatments widely used for managing neuropathic and musculoskeletal pain. However, not all phytochemicals have demonstrated consistent efficacy in managing neuropathic pain, and their effects can vary depending on the compound and the specific condition. The pathophysiology of neuropathic pain, involving maladaptive changes in the somatosensory nervous system, peripheral and central sensitization, and glial cell activation, is also outlined. Overall, this review emphasizes the need for continued high-quality clinical studies to fully establish the therapeutic potential of phytochemicals in neuropathic pain management.Keywords
This publication has 121 references indexed in Scilit:
- Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviewsCochrane Database of Systematic Reviews, 2013
- Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human EvidenceCurrent Pharmaceutical Design, 2013
- Opioids for neuropathic painCochrane Database of Systematic Reviews, 2013
- A Controlled Study of a Lecithinized Delivery System of Curcumin (Meriva®) to Alleviate the Adverse Effects of Cancer TreatmentPhytotherapy Research, 2013
- Guillain-Barré Syndrome and VariantsNeurologic Clinics, 2013
- Antinociceptive effects of matrine on neuropathic pain induced by chronic constriction injuryPharmaceutical Biology, 2013
- TNF-α enhances the currents of voltage gated sodium channels in uninjured dorsal root ganglion neurons following motor nerve injuryExperimental Neurology, 2011
- Effect of Oral Curcumin on Déjérine-Sottas DiseasePediatric Neurology, 2009
- Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in ratsExperimental Neurology, 2008
- Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic painProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2003